Amphastar Pharmaceuticals (AMPH) News Today $35.70 +0.04 (+0.11%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Amphastar stock hits 52-week low at $34.6 amid market challengesJanuary 16 at 3:52 PM | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 52-Week Low - Here's WhyAmphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 12-Month Low - Here's WhyJanuary 16 at 1:54 PM | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 2.4% - Should You Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 2.4% - What's Next?January 15 at 12:26 PM | marketbeat.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 9, 2025 | finanznachrichten.deAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Up 4.6% - Here's What HappenedAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading 4.6% Higher - Time to Buy?January 8, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - What's Next?Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low - What's Next?January 6, 2025 | marketbeat.comAmphastar Pharmaceuticals: Cheap With CaveatsJanuary 3, 2025 | seekingalpha.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 6.1% in DecemberAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 4,370,000 shares, a growth of 6.1% from the November 30th total of 4,120,000 shares. Based on an average daily volume of 424,600 shares, the days-to-cover ratio is currently 10.3 days. Currently, 12.2% of the company's shares are short sold.January 1, 2025 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 1-Year Low - Here's What HappenedAmphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month Low - Time to Sell?December 31, 2024 | marketbeat.comPrincipal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Principal Financial Group Inc. decreased its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 7.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 202,017 sharesDecember 31, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 2.6% - Here's What HappenedAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 2.6% - Here's WhyDecember 24, 2024 | marketbeat.comGeode Capital Management LLC Has $44.67 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Geode Capital Management LLC grew its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 1.5% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 920,363 shares of the company's stock after buying an adDecember 24, 2024 | marketbeat.comBarclays PLC Has $3.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Barclays PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 53.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 74,456 shares of the company's stock after acquiring an additional 2December 23, 2024 | marketbeat.comWellington Management Group LLP Acquires New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Wellington Management Group LLP bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 19,723 shares of the company'sDecember 20, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells $310,940.00 in StockDecember 17, 2024 | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) EVP Rong Zhou sold 7,000 shares of the business's stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $44.42, for a total transaction of $310,940.00. Following the sale, the executive vice president now directly owns 118,469 shares in the company, valued at approximately $5,262,392.98. This represents a 5.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.December 16, 2024 | marketbeat.comWorld Investment Advisors LLC Invests $1.61 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)World Investment Advisors LLC bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 33,249 shares of the company's stocDecember 15, 2024 | marketbeat.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4% - Here's WhyAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 5.4% - Time to Sell?December 13, 2024 | marketbeat.comXTX Topco Ltd Invests $674,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)XTX Topco Ltd purchased a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 13,891 shares of the company's stock, valued at approximatelyDecember 13, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells $437,700.00 in StockDecember 12, 2024 | insidertrades.comCentiva Capital LP Sells 17,110 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Centiva Capital LP lessened its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 72.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,465 shares of the company's stock after selling 17,110 shaDecember 11, 2024 | marketbeat.comPoint72 Asset Management L.P. Sells 197,019 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Point72 Asset Management L.P. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 83.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 38,817 shares of the company's stock after selling 197,019 shares during theDecember 10, 2024 | marketbeat.comTaika Capital LP Buys New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Taika Capital LP bought a new stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 36,775 shares of the company's stock, valued atDecember 6, 2024 | marketbeat.comHotchkis & Wiley Capital Management LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Hotchkis & Wiley Capital Management LLC purchased a new position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 222,620 shares of the company's stock, valDecember 5, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 59.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,466 shares of the companDecember 4, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Dynamic Technology Lab Private LtdDynamic Technology Lab Private Ltd lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 70.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,682 shares of the company's stock after sellinDecember 3, 2024 | marketbeat.comGlenmede Trust Co. NA Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Glenmede Trust Co. NA lifted its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 145.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 37,884 shares of the company'December 2, 2024 | marketbeat.comWhy Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?November 30, 2024 | msn.comAmphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare ConferenceNovember 27, 2024 | finanznachrichten.deAlgert Global LLC Takes $3.22 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Algert Global LLC bought a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 66,285 shares of the company's stock, valNovember 26, 2024 | marketbeat.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Holdings Lessened by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. cut its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 19.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 83,673 shares of the company's stock after selling 20,448 shares during thNovember 24, 2024 | marketbeat.com18,968 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Segall Bryant & Hamill LLCSegall Bryant & Hamill LLC bought a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 18,968 shares of the company's stock, valued at approximateNovember 24, 2024 | marketbeat.comAmphastar initiated with an Equal Weight at Wells FargoNovember 23, 2024 | markets.businessinsider.comWells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight RecommendationNovember 23, 2024 | msn.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated by Analysts at Wells Fargo & CompanyWells Fargo & Company began coverage on Amphastar Pharmaceuticals in a research note on Friday. They issued an "equal weight" rating and a $55.00 target price for the company.November 22, 2024 | marketbeat.comVictory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Victory Capital Management Inc. increased its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) by 10.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 218,531 shares of the company's stockNovember 21, 2024 | marketbeat.comLos Angeles Capital Management LLC Takes $785,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)Los Angeles Capital Management LLC purchased a new position in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 16,169 shares of the coNovember 16, 2024 | marketbeat.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Director Sells 5,000 Shares of StockNovember 14, 2024 | insidertrades.comInsider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of StockNovember 9, 2024 | insidertrades.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 7,426 SharesNovember 9, 2024 | insidertrades.comWilliam J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) StockAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH - Get Free Report) CFO William J. Peters sold 7,426 shares of the stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.05, for a total transaction of $386,523.30. Following the transaction, the chief financial officer now owns 94,103 shares in the company, valued at approximately $4,898,061.15. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.November 8, 2024 | marketbeat.comNeedham Remains a Hold on Amphastar Pharmaceuticals (AMPH)November 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals Reports Strong Q3 2024 ResultsNovember 8, 2024 | markets.businessinsider.comAmphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | insidermonkey.comAmphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down - Time to Sell?November 7, 2024 | marketbeat.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...November 7, 2024 | finance.yahoo.comAmphastar Pharmaceuticals Inc. (AMPH) Q3 2024 Earnings Call TranscriptNovember 6, 2024 | seekingalpha.comAmphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to ExpectNovember 5, 2024 | finance.yahoo.comAmphastar Pharmaceuticals (NASDAQ:AMPH) Downgraded to Hold Rating by StockNews.comStockNews.com cut Amphastar Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Friday.November 1, 2024 | marketbeat.com Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address AMPH Media Mentions By Week AMPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMPH News Sentiment▼-0.120.64▲Average Medical News Sentiment AMPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMPH Articles This Week▼44▲AMPH Articles Average Week Get Amphastar Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RVMD News Today LNTH News Today BPMC News Today BBIO News Today LEGN News Today ELAN News Today CYTK News Today GRFS News Today NUVL News Today VKTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMPH) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMPH Stock Alerts